Nuvectis Pharma CEO Ron Bentsur's 2023 pay jumps 59% to $2.7M
Nuvectis Pharma reports 2023 executive compensation
By ExecPay News
Published: April 29, 2024
Nuvectis Pharma reported fiscal year 2023 executive compensation information on April 29, 2024.
In 2023, three executives at Nuvectis Pharma received on average a compensation package of $1.9M, a 61% increase compared to previous year.
Average pay of disclosed executives at Nuvectis Pharma
Ron Bentsur, Chief Executive Officer, received $2.7M in total, which increased by 59% compared to 2022. 58% of Bentsur's compensation, or $1.6M, was in stock awards. Bentsur also received $509K in bonus and $615K in salary.
Enrique Poradosu, Chief Scientific & Business Officer, received a compensation package of $1.6M, which increased by 61% compared to previous year. 55% of the compensation package, or $858K, was in stock awards.
Shay Shemesh, Chief Development & Operations Officer, earned $1.6M in 2023, a 64% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2024.